We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $702M | 15.34% |
+940,000
| New | +$682M |
2026 Q2
0 quarters
|
|
|
2
SpaceX
SPCX
$2T
| $102M | 2.23% |
+596,829
| New | +$101M |
2026 Q2
0 quarters
|
|
|
3
JPMorgan Chase
JPM
$881B
| $83.5M | 1.82% |
+254,986
| New | +$79.2M |
2026 Q2
0 quarters
|
|
4
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$46.6B
| $77.3M | 1.69% |
+487,500
| New | +$72.5M |
2026 Q2
0 quarters
|
|
5
Bank of America
BAC
$350B
| $74M | 1.62% |
1,299,450
-256,211
| -16% | -$13.6M |
2026 Q1
1 quarter
|
|
|
6
PUT
Goldman Sachs
GS
$255B
| $73.8M | 1.61% |
+73,000
| New | +$71.2M |
2026 Q2
0 quarters
|
|
7
CALL
Pfizer
PFE
$171B
| $71.8M | 1.57% |
2,980,000
+2,500,000
| +521% | +$65.4M |
2026 Q1
1 quarter
|
|
|
8
Fifth Third Bancorp
FITB
$48B
| $65.1M | 1.42% |
+1,154,808
| New | +$58.5M |
2026 Q2
0 quarters
|
|
9
Huntington Bancshares
HBAN
$31.8B
| $59.7M | 1.3% |
+3,368,279
| New | +$55.6M |
2026 Q2
0 quarters
|
|
|
10
Moody's
MCO
$83.4B
| $59.3M | 1.29% |
+130,864
| New | +$58.8M |
2026 Q2
0 quarters
|
|
11
Mettler-Toledo International
MTD
$33.5B
| $53.6M | 1.17% |
41,960
+32,710
| +354% | +$39.4M |
2026 Q1
1 quarter
|
|
|
12
LPL Financial
LPLA
$24.9B
| $52.6M | 1.15% |
+186,650
| New | +$56M |
2026 Q2
0 quarters
|
|
13
US Bancorp
USB
$92.8B
| $47.2M | 1.03% |
782,007
+28,668
| +4% | +$1.61M |
2026 Q1
1 quarter
|
|
14
Morgan Stanley
MS
$281B
| $47.1M | 1.03% |
225,079
-88,406
| -28% | -$17.5M |
2025 Q4
2 quarters
|
|
15
StubHub Holdings
STUB
$2.24B
| $43.2M | 0.94% |
+3,352,993
| New | +$29.6M |
2026 Q2
0 quarters
|
|
16
CALL
Boston Scientific
BSX
$66.2B
| $42.7M | 0.93% |
1,000,000
+500,000
| +100% | +$27.2M |
2026 Q1
1 quarter
|
|
17
MiniMed Group Inc
MMED
$5.16B
| $42.1M | 0.92% |
2,812,970
-365,684
| -12% | -$4.82M |
2026 Q1
1 quarter
|
|
|
18
Vishay Intertechnology
VSH
$4.1B
| $41.1M | 0.9% |
764,322
-1,132,889
| -60% | -$46.3M |
2026 Q1
1 quarter
|
|
19
TPG
TPG
$7.44B
| $40.7M | 0.89% |
+1,004,864
| New | +$42.3M |
2026 Q2
0 quarters
|
|
20
PUT
Invesco QQQ Trust
QQQ
$475B
| $40.1M | 0.88% |
54,500
-715,500
| -93% | -$492M |
2026 Q1
1 quarter
|
|
21
Parker-Hannifin
PH
$111B
| $39M | 0.85% |
39,889
+29,788
| +295% | +$27.3M |
2026 Q1
1 quarter
|
|
22
uniQure
QURE
$1.56B
| $37.1M | 0.81% |
+804,594
| New | +$21.1M |
2026 Q2
0 quarters
|
|
23
UnitedHealth
UNH
$375B
| $37M | 0.81% |
88,930
+68,930
| +345% | +$25.5M |
2025 Q3
3 quarters
|
|
24
Visa
V
$766B
| $35.4M | 0.77% |
+103,310
| New | +$33.2M |
2026 Q2
0 quarters
|
|
25
KeyCorp
KEY
$22.5B
| $35M | 0.76% |
1,518,711
-1,454,259
| -49% | -$31.7M |
2026 Q1
1 quarter
|
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.